Tags

Type your tag names separated by a space and hit enter

The polypill strategy in cardiovascular disease prevention: It's time for its implementation.
Prog Cardiovasc Dis. 2023 Mar 15 [Online ahead of print]PC

Abstract

A polypill strategy has been demonstrated to improve treatment adherence in several cardiovascular disease (CVD) settings. However, data on the prognostic impact in the secondary prevention setting have been scarce. The Secondary Prevention of Cardiovascular Disease in the Elderly trial, the results of which have been recently published, has demonstrated a benefit in terms of major adverse CVD event reduction. This finding, in addition to previous evidence, should lead to a broader polypill implementation in CVD prevention.

Links

Publisher Full Text (DOI)

Authors+Show Affiliations

Clinical and Rehabilitation Cardiology Unit, Emergency Department, San Filippo Neri Hospital, ASL Rome 1, Rome, Italy. Electronic address: stefaniaa.difusco@aslroma1.it.

Clinical and Rehabilitation Cardiology Unit, Emergency Department, San Filippo Neri Hospital, ASL Rome 1, Rome, Italy.

Clinical and Rehabilitation Cardiology Unit, Emergency Department, San Filippo Neri Hospital, ASL Rome 1, Rome, Italy.

Clinical and Rehabilitation Cardiology Unit, Emergency Department, San Filippo Neri Hospital, ASL Rome 1, Rome, Italy.

Clinical and Rehabilitation Cardiology Unit, Emergency Department, San Filippo Neri Hospital, ASL Rome 1, Rome, Italy.

Clinical and Rehabilitation Cardiology Unit, Emergency Department, San Filippo Neri Hospital, ASL Rome 1, Rome, Italy.

Internal Medicine Unit, Emergency Department, San Filippo Neri Hospital, ASL Rome 1, Rome, Italy.

Clinical and Rehabilitation Cardiology Unit, Emergency Department, San Filippo Neri Hospital, ASL Rome 1, Rome, Italy.

Pub Type(s)

Journal Article

Review

Language

eng

PubMed ID

36931543

Citation

Di Fusco, Stefania Angela, et al. "The Polypill Strategy in Cardiovascular Disease Prevention: It's Time for Its Implementation." Progress in Cardiovascular Diseases, 2023.

Di Fusco SA, Aquilani S, Spinelli A, et al. The polypill strategy in cardiovascular disease prevention: It's time for its implementation. Prog Cardiovasc Dis. 2023.

Di Fusco, S. A., Aquilani, S., Spinelli, A., Alonzo, A., Matteucci, A., Castello, L., Imperoli, G., & Colivicchi, F. (2023). The polypill strategy in cardiovascular disease prevention: It's time for its implementation. Progress in Cardiovascular Diseases. https://doi.org/10.1016/j.pcad.2023.03.003

Di Fusco SA, et al. The Polypill Strategy in Cardiovascular Disease Prevention: It's Time for Its Implementation. Prog Cardiovasc Dis. 2023 Mar 15; PubMed PMID: 36931543.

* Article titles in AMA citation format should be in sentence-case

TY - JOUR T1 - The polypill strategy in cardiovascular disease prevention: It's time for its implementation. AU - Di Fusco,Stefania Angela, AU - Aquilani,Stefano, AU - Spinelli,Antonella, AU - Alonzo,Alessandro, AU - Matteucci,Andrea, AU - Castello,Lorenzo, AU - Imperoli,Giuseppe, AU - Colivicchi,Furio, Y1 - 2023/03/15/ PY - 2023/03/13/received PY - 2023/03/13/accepted PY - 2023/3/18/pubmed PY - 2023/3/18/medline PY - 2023/3/17/entrez KW - Atherosclerosis KW - Cardiovascular disease KW - Myocardial infarction KW - Polypill KW - Prevention JF - Progress in cardiovascular diseases JO - Prog Cardiovasc Dis N2 - A polypill strategy has been demonstrated to improve treatment adherence in several cardiovascular disease (CVD) settings. However, data on the prognostic impact in the secondary prevention setting have been scarce. The Secondary Prevention of Cardiovascular Disease in the Elderly trial, the results of which have been recently published, has demonstrated a benefit in terms of major adverse CVD event reduction. This finding, in addition to previous evidence, should lead to a broader polypill implementation in CVD prevention. SN - 1873-1740 UR - https://www.unboundmedicine.com/medline/citation/36931543/The_polypill_strategy_in_cardiovascular_disease_prevention:_It's_time_for_its_implementation_ DB - PRIME DP - Unbound Medicine ER -